Form 4: Lifeway Foods Director Jody Levy Reports Future RSU Vesting and Share Acquisition
Insider Transaction Report
Lifeway Foods Director Jody Levy filed a Form 4 disclosing the future vesting of 1,356 restricted stock units into common stock on July 1, 2025, increasing her direct beneficial ownership to 26,847 shares.
Summary
- Jody Levy, a Director of Lifeway Foods, Inc. (LWAY), filed a Form 4 statement of changes in beneficial ownership.
- The filing reports a transaction dated July 1, 2025, involving the acquisition of 1,356 shares of common stock.
- This acquisition is due to the vesting of restricted stock units (RSUs) at a price of $0 per share.
- Following this transaction, Ms. Levy's direct beneficial ownership of Lifeway Foods common stock will be 26,847 shares.
- She also holds additional unvested restricted stock units: 1,600 RSUs scheduled to vest on August 31, 2025; 1,551 RSUs scheduled to vest on August 31, 2025, and 1,550 RSUs scheduled to vest on August 31, 2026; and 1,356 RSUs scheduled to vest on July 1, 2026, and 1,354 RSUs scheduled to vest on July 1, 2027. All vestings are contingent on her continued service as a Director.
Sentiment
Score: 6
Explanation: The filing reports a routine vesting of restricted stock units for a director, which is a standard component of executive compensation. The increase in direct beneficial ownership aligns the director's interests with shareholders, which is generally a positive signal, though the transaction itself is not indicative of new strategic developments or financial performance.
Positives
- The vesting of restricted stock units aligns the director's interests with those of shareholders.
- The continued accumulation of shares by a director indicates ongoing commitment and confidence in the company's future.
Risks
- The vesting of all reported restricted stock units is contingent upon the reporting person's continued service as a Director on the specified vesting dates.
Future Outlook
The reporting person has a future vesting schedule for additional restricted stock units, with significant tranches scheduled to vest on August 31, 2025, July 1, 2026, August 31, 2026, and July 1, 2027, contingent on continued service as a Director.
Industry Context
This Form 4 filing is a routine disclosure of insider equity transactions, common across all publicly traded companies, and does not inherently reflect broader industry trends or competitive dynamics.
Related Party Transactions
- Acquisition of 1,356 common shares by Director Jody Levy through the vesting of restricted stock units, a form of equity compensation from Lifeway Foods, Inc.
Stakeholder Impact
- Shareholders: The transaction increases the director's equity stake, enhancing alignment of interests between the director and shareholders.
Next Steps
- Vesting of 1,600 restricted stock units on August 31, 2025.
- Vesting of 1,551 restricted stock units on August 31, 2025.
- Vesting of 1,356 restricted stock units on July 1, 2026.
- Vesting of 1,550 restricted stock units on August 31, 2026.
- Vesting of 1,354 restricted stock units on July 1, 2027.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Transaction date for the acquisition of 1,356 common shares from RSU vesting. |
| 08/31/2025 | Vesting date for 1,600 restricted stock units and 1,551 restricted stock units. |
| 07/01/2026 | Vesting date for 1,356 restricted stock units. |
| 08/31/2026 | Vesting date for 1,550 restricted stock units. |
| 07/01/2027 | Vesting date for 1,354 restricted stock units. |
Recommendation
holdKeywords
Lifeway Foods, LWAY, Form 4, SEC filing, beneficial ownership, restricted stock units, RSU, insider transaction, director, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.